GSK and Daiichi Sankyo eye leading vaccines position in Japan via new JV

GlaxoSmithKline and Daiichi Sankyo have now confirmed that they will set up a vaccines joint venture in Japan to handle existing and future products from both partners, following local media leaks of a tie-up ahead of the formal announcement.